Sreedhar Katragadda MD

Oncology•Reidsville, NC

Hematologic Oncology

Physician

Join to View Full Profile

618 S Main StReidsville, NC 27320
Phone+1 336-951-4501
Fax+1 276-666-7566

Education & Training

Westchester Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
Westchester Medical CenterResidency, Internal Medicine, 2003 - 2006
Siddhartha Medical College NTRClass of 2000

Certifications & Licensure

FL State Medical License 2024 - 2027
VA State Medical License 2009 - 2026
NC State Medical License 2018 - 2025
MN State Medical License 2009 - 2009
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
ACTIVE_NOT_RECRUITING
PHASE3
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
ACTIVE_NOT_RECRUITING
PHASE3
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Completed
Phase 3
S0820, Adenoma and Second Primary Prevention Trial Start of enrollment: 2013 Aug 23
ACTIVE_NOT_RECRUITING
PHASE3
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Start of enrollment: 2013 Aug 27
ACTIVE_NOT_RECRUITING
PHASE2
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2014 Mar 10
ACTIVE_NOT_RECRUITING
PHASE3
Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis Start of enrollment: 2014 Mar 21
Completed
Phase 3
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic Start of enrollment: 2014 Mar 29
ACTIVE_NOT_RECRUITING
PHASE3
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

1 citations
Psychological predictors of chemotherapy-induced nausea in women with breast cancer: Expectancies and perceived susceptibility.
Elise J. Devlin, Hayley S. Whitford, Anita R. Peoples, Gary R. Morrow, Sreedhar Katragadda
European Journal of Cancer Care. 2021-07-29
29 citations
Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance)
Jonathan E. Rosenberg, Karla A Ballman, Susan Halabi, Pamela J. Atherton, Amir Mortazavi
Journal of Clinical Oncology. 2021-05-14
18 citations
Temozolomide and cisplatin in relapsed/refractory acute leukemia
Karen Seiter, Sreedhar Katragadda, Doris Ponce, Muhammad Rasul, Nasir Ahmed
Journal of Hematology & Oncology. 2009-05-22

Sreedhar Katragadda MD

Dr. Katragadda is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Viewing the full profile is available to verified healthcare professionals only.